PF

Paul R. Fatheree

TI Theravance Biopharma R&D Ip: 3 patents #2 of 40Top 5%
📍 San Francisco, CA: #340 of 6,999 inventorsTop 5%
🗺 California: #3,757 of 65,961 inventorsTop 6%
Overall (2022): #28,459 of 548,613Top 6%
5
Patents 2022

Issued Patents 2022

Showing 1–5 of 5 patents

Patent #TitleCo-InventorsDate
11453668 JAK inhibitors containing a 4-membered heterocyclic amide Gary E. L. Brandt, Cameron Smith, Steven D. E. Sullivan, Lori Jean Van Orden 2022-09-27
11447468 IL-17 ligands and uses thereof Martin S. Linsell, John R. Jacobsen, Wouter A. VAN DER LINDEN, Timothy J. Church, Claudio Aquino +1 more 2022-09-20
11299492 JAK kinase inhibitor compounds for treatment of respiratory disease John R. Jacobsen, Gary E. L. Brandt, Melissa Fleury, Lan Jiang, Cameron Smith +3 more 2022-04-12
11274094 Substituted benzenecarboxamides as IL-17A modulators Martin S. Linsell, John R. Jacobsen, Wouter A. VAN DER LINDEN, Timothy J. Church, Claudio Aquino +1 more 2022-03-15
11254669 Fused imidazo-piperidine JAK inhibitors Gary E. L. Brandt, Cameron Smith, Steven D. E. Sullivan, Lori Jean Van Orden 2022-02-22